Low Testosterone and Mental Health: Depression, Anxiety Risk
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
Hypogonadism (Condition)
15 source-based articles maintained by the HealthRX.com Editorial Team.
15articles
6topic areas covered
May 26, 2026latest review
Hypogonadism (Condition) library
Showing 15 of 15 clinical reviews.
Male Hypogonadism Exercise Prescription: What the Evidence Actually Supports
A guide to exercise protocols for male hypogonadism, covering resistance training, aerobic exercise, frequency, intensity, and how structured movement affects testosterone, muscle mass, and metabolic health.
Male Hypogonadism Guidelines Compared: ADA, AACE, Endocrine Society, AUA, and EAU
A side-by-side comparison of the major clinical practice guidelines for diagnosing and treating male hypogonadism, including testosterone thresholds, testing protocols, and treatment recommendations from the Endocrine Society, AUA, AACE, ADA, and EAU.
Male Hypogonadism in Special Populations
Evidence-based guide to diagnosing and treating male hypogonadism in special populations including obesity, type 2 diabetes, HIV, opioid users, older men, chronic kidney disease, and cancer survivors.
Male Hypogonadism Monitoring Schedule: When to Test and What to Track on TRT
A detailed, guideline-based monitoring schedule for men on testosterone replacement therapy (TRT), covering baseline labs, 3-month check-ins, 6-month evaluations, and annual assessments per Endocrine Society and AUA recommendations.
Male Hypogonadism Socioeconomic Impact: Costs, Productivity, and Quality of Life
A comprehensive review of the socioeconomic burden of male hypogonadism, including direct medical costs, lost productivity, mental health consequences, and the cost-effectiveness of testosterone replacement therapy.
Male Hypogonadism Treatment Algorithm: A Line-by-Line Therapy Guide
A step-by-step guide to confirming male hypogonadism, identifying its cause, choosing fertility-focused treatment or TRT, and tracking treatment response.
Male Hypogonadism: Common Comorbidities and Clinical Overlap
Male hypogonadism shares strong bidirectional links with obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, osteoporosis, and depression. Learn how these conditions overlap and what guidelines recommend.
Male Hypogonadism: Emerging Research and Trials to Watch
A clinical review of the most promising emerging research, active clinical trials, and next-generation therapies for male hypogonadism, including oral testosterone, selective androgen receptor modulators, and kisspeptin-based treatments.
Male Hypogonadism: Genetics and Family History
How genetics and family history influence male hypogonadism risk, which heritable conditions cause low testosterone, and what genetic testing and screening options exist for men and their families.
Male Hypogonadism: Global Prevalence and Trends
A overview of male hypogonadism prevalence worldwide, secular trends, risk factors, and what the latest epidemiological data mean for diagnosis and treatment.
Male Hypogonadism: History of Treatment Over Decades
A timeline of male hypogonadism treatment from 19th-century organotherapy through modern testosterone formulations, GnRH-based therapies, and emerging peptide research, with an evidence-boundary review of which historical claims are well established and which need verification.
Male Hypogonadism: Nutrition and Lifestyle Protocols That Support Testosterone
For obese men with low testosterone, the Endocrine Society recommends lifestyle change first: 5-10% weight loss, resistance training, 7-9 hours of sleep.
Male Hypogonadism: Rare and Atypical Presentations Clinicians Miss
A clinical deep-dive into rare and atypical presentations of male hypogonadism, including fertile eunuch syndrome, Kallmann syndrome variants, late-onset hypogonadism without classic symptoms, and medication-induced forms, with primary-source citations and practical diagnostic guidance.
Testosterone Deficiency Diagnosis: Endocrine Society Guideline
Diagnosis requires two morning total testosterone results below 300 ng/dL, confirmed symptoms, then LH and FSH to classify primary vs secondary hypogonadism.